Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100 (Leukemia, (2022), 36, 5, (1429-1431), 10.1038/s41375-022-01529-w)

Alissa Visram, S. Vincent Rajkumar, Prashant Kapoor, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Taxiarchis Kourelis, Wilson Gonsalves, Rahma Warsame, Eli Muchtar, Nelson Leung, Robert A. Kyle, Shaji K. Kumar

Research output: Contribution to journalComment/debatepeer-review

Abstract

It has been brought to our attention that the figure in the letter has an error. In the figure legend, the description corresponding to the red line should have a "≥" instead of a "<". The updated figure is shown below.

Original languageEnglish (US)
Pages (from-to)1699
Number of pages1
JournalLeukemia
Volume36
Issue number6
DOIs
StatePublished - Jun 2022

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100 (Leukemia, (2022), 36, 5, (1429-1431), 10.1038/s41375-022-01529-w)'. Together they form a unique fingerprint.

Cite this